Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer
Virchows Archiv · 2025
DOI: 10.1007/s00428-024-03737-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virchows Archiv, 2025. Verfasst von Dovile Zilenaite-Petrulaitiene und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Informatics, Faculty of Mathematics and Informatics, Vilnius University, Naugarduko Str. 24, 03225, Vilnius, Lithuania. dovile.zilenaite…. Hauptthemen laut MEDLINE: Ki-67 Antigen, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Immunohistochemistry. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
In breast cancer (BC), pathologists visually score ER, PR, HER2, and Ki67 biomarkers to assess tumor properties and predict patient outcomes. This does not systematically account for intratumoral heterogeneity (ITH) which has been reported to provide prognostic value. This study utilized digital image analysis (DIA) and computational pathology methods to investigate the prognostic value of ITH indicators in ER-positive (ER+) HER2-negative (HER2-) BC patients. Whole slide images (WSIs) of surgically excised specimens stained for ER, PR, Ki67, and HER2 from 254 patients were used. DIA with tumor tissue segmentation and detection of biomarker-positive cells was performed. The DIA-generated data were subsampled by a hexagonal grid to compute Haralick's texture indicators for ER, PR, and Ki67. Cox regression analyses were performed to assess the prognostic significance of the immunohistochemistry (IHC) and ITH indicators in the context of clinicopathologic variables. In multivariable analysis, the ITH of Ki67-positive cells, measured by Haralick's texture entropy, emerged as an independent predictor of worse BC-specific survival (BCSS) (hazard ratio (HR) = 2.64, p-value = 0.0049), along with lymph node involvement (HR = 2.26, p-value = 0.0195). Remarkably, the entropy representing the spatial disarrangement of tumor proliferation outperformed the proliferation rate per se established either by pathology reports or DIA. We conclude that the Ki67 entropy indicator enables a more comprehensive risk assessment with regard to BCSS, especially in cases with borderline Ki67 proliferation rates. The study further demonstrates the benefits of high-capacity DIA-generated data for quantifying the essentially subvisual ITH properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Informatics, Faculty of Mathematics and Informatics, Vilnius University, Naugarduko Str. 24, 03225, Vilnius, Lithuania. dovile.zilenaite@vpc.lt.
- Department of Pathology and Forensic Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Ciurlionio Str. 21, 03101, Vilnius, Lithuania. dovile.zilenaite@vpc.lt.
- National Centre of Pathology, affiliate of Vilnius University Hospital Santaros Klinikos, P. Baublio Str. 5, 08406, Vilnius, Lithuania. dovile.zilenaite@vpc.lt.
- Department of Pathology and Forensic Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Ciurlionio Str. 21, 03101, Vilnius, Lithuania.
- National Centre of Pathology, affiliate of Vilnius University Hospital Santaros Klinikos, P. Baublio Str. 5, 08406, Vilnius, Lithuania.
- Path-Image/BioTiCla, University of Caen Normandy, François Baclesse Comprehensive Cancer Center, 3 Av. du Général Harris, 14000, Caen, France.
Zitieren
APA
Zilenaite-Petrulaitiene, D., Rasmusson, A., Besusparis, J., Valkiuniene, R. B., Augulis, R., Laurinaviciene, A., Plancoulaine, B., Petkevicius, L., & Laurinavicius, A. (2025). Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer. Virchows Archiv. https://doi.org/10.1007/s00428-024-03737-4
Vancouver
Zilenaite-Petrulaitiene D, Rasmusson A, Besusparis J, Valkiuniene RB, Augulis R, Laurinaviciene A, et al. Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer. Virchows Archiv. 2025. doi:10.1007/s00428-024-03737-4
BibTeX
@article{ZilenaitePetrulaitiene2025,
author = {Zilenaite-Petrulaitiene, Dovile and Rasmusson, Allan and Besusparis, Justinas and Valkiuniene, Ruta Barbora and Augulis, Renaldas and Laurinaviciene, Aida and Plancoulaine, Benoit and Petkevicius, Linas and Laurinavicius, Arvydas},
title = {Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer},
journal = {Virchows Archiv},
year = {2025},
doi = {10.1007/s00428-024-03737-4}
}
EUVIMED